The 54 page ‘White Paper’, developed by The University of Sydney Community Placement Program in Partnership with MGC Pharmaceuticals, is a solid endorsement for MGC in the new MC field within Australia. This massive credibility boost puts MGC clearly at the front of the queue for future Govt and / or privately funded work to advance the many applications and benefits that MC has to offer.
No doubt, the company continues to make strong and positive steps forward in a bid to become a world leader in the global CBD based cosmeceutical market.
MXC Price at posting:
3.0¢ Sentiment: Buy Disclosure: Held
